Immuneering Corporation (IMRX) Tops Q1 EPS by 5c

Immuneering Corporation (NASDAQ: IMRX) reported Q1 EPS of ($0.44), $0.05 better than the analyst estimate of ($0.49).

For earnings history and earnings-related data on Immuneering Corporation (IMRX) click here.

You May Also Be Interested In

• La-Z-Boy (LZB) Misses Q1 EPS by 6c, Misses on Revenue; Offers Weak Q2 Revenue Guidance
• Polar Power adds two directors with defense and business experience
• SharonAI Holdings (SHAZ) files for 8.02M share offering by selling stockholders